Journal profile · Multiple

Rare Disease and Orphan Drugs Journal

ISSN 2771-2893

Rare Disease and Orphan Drugs Journal: hybrid open access; 35 articles in 2025; indexed in ESCI.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review time—No reports yet
APC—No source gives fee information
Acceptance—No reports yet
Articles per year352025 · OpenAlex count
Indexed inESCILetPub

Scope

Aims, scope and focus

By OpenAlex counts of its recent articles, Rare Disease and Orphan Drugs Journal's largest topics are Genomics and Rare Diseases, Lysosomal Storage Disorders Research and Metabolism and Genetic Disorders, together about 42.8% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Multiple

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology15.7%
  2. Lysosomal Storage Disorders ResearchMedicine14.5%
  3. Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology12.5%
  4. Glycogen Storage Diseases and MyoclonusMedicine8.9%
  5. Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology4%
  6. Systemic Lupus Erythematosus ResearchMedicine3.6%
  7. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance3.6%
  8. Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology3.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCILetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

h-index
10OpenAlex ·
i10-index
10OpenAlex ·
2-year mean citedness
1.52OpenAlex ·
Self-citation rate
5.3%LetPub ·
Share of gold OA articles
74.12%LetPub ·
Articles per year
33LetPub ·

Articles by year OpenAlex count · 149 in total · the current year is incomplete

YearArticlesOpen accessCitations
20263529133
20253535146
20243333102
2023281922
202213136
2021541

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Before you submit

Three checks before submitting to Rare Disease and Orphan Drugs Journal

  1. 1
    ScopeRecent output centres on Genomics and Rare Diseases, Lysosomal Storage Disorders Research.
    Check scope
  2. 2
    Article type and formatPrepare text, figures and references as the author guidelines ask.
  3. 3
    English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.

The checks are built from this page's data.

Profile

Publication details and official links

ISSN
2771-2893

FAQ

Frequently asked questions about Rare Disease and Orphan Drugs Journal

Which databases index Rare Disease and Orphan Drugs Journal?

According to LetPub and DOAJ records, Rare Disease and Orphan Drugs Journal is indexed in ESCI.

Is Rare Disease and Orphan Drugs Journal open access, and what is the APC?

Rare Disease and Orphan Drugs Journal is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .